Globe Newswire
Gross Margin Improvement of 235 bps46.2% in Q1/2024, Up From 43.9% in Q1/2023Adjusted Gross Margin Improvement of 265 bps49.8% in Q1/2024, Up From 47.1% in Q1/2023
“Reshaping Nano Initiative” Taking Effect with 75% Improvement in Net Cash Burn$7.0M in Q1/2024, Compared to $27.4M in Q1/2023
Outstanding Shares Reduced by 15% to 219 Million, Over the Last 15 Months
Strong Capital Position and Cash Management Keeps Company On Previously Announced Path of Net Cash... (continue reading...)
NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- EXL [NASDAQ: EXLS], a leading data analytics and digital operations and solutions company, today announced that it has been named a Leader in the 2024 Gartner Magic Quadrant for Finance and Accounting (F&A) Business Process Outsourcing (BPO).
The Gartner research report evaluated 18 F&A service providers according to a uniform set of criteria, placing companies into four Quadrants: Leaders, Visionaries, Niche Players and... (continue reading...)
TORONTO, June 03, 2024 (GLOBE NEWSWIRE) -- African Rainbow Minerals Limited (JSE: ARI) (A2X: ARI) (“ARM”) announces that it has purchased 41,373,414 common shares (“Surge Shares”) in the capital of Surge Copper Corp. (“Surge”) pursuant to a non-brokered private placement at a price of C$0.095 per share for total consideration of approximately C$3,930,474.33 (the “Private Placement”).
Immediately prior to the Private Placement, ARM held no Surge Shares... (continue reading...)
FLORHAM PARK, N.J., June 03, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ: CELU) (“Celularity”), a regenerative and cellular medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, announced today that it presented in vivo data from its T-cell therapy platform at this year’s ASCO Annual Meeting in Chicago. These data show that PT-CD16VS, Celularity’s T-Cell preclinical asset, has potent in vitro and in... (continue reading...)
LOS ANGELES, June 03, 2024 (GLOBE NEWSWIRE) -- IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Stock2Me Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels.
The Stock2Me Podcast features a fascinating array of companies and individuals, many of whom are actively... (continue reading...)
More Globe Newswire
View Older Stories-
German American Bancorp, Inc. announces the sale of the assets of German American Insurance, Inc. to Hilb Group
-
GDS to Hold Annual General Meeting on June 27, 2024
-
Paradies Lagardère Introduces ARHT Holograms in New Retail Experience at Toronto Pearson International Airport
-
KP Tissue Reminds Shareholders to Vote in Advance of Deadline for 2024 Annual Meeting of Shareholders
-
electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules
-
Safety Shot, World’s First Beverage to Reduce Blood Alcohol Content, Announces Launch of New 4-Ounce Bottles
-
TIAN RUIXIANG Holdings Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement and Receives an Extension on Compliance with Nasdaq Filing Requirement
-
Lantheus’ AI-Enabled aPROMISE Now Available on Siemens Healthineers’ syngo.via platform
-
FDA Provides Feedback and Reaches Consensus on Nexalin’s Design for Planned Anxiety and Insomnia Clinical Studies of its Gen-3 HALO Clarity™ Headset Device
-
LIXTE Biotechnology Holdings Names Distinguished Oncologist Jan Schellens as Chief Medical Officer
-
Qlik Signs Strategic Collaboration Agreement with AWS to Accelerate Enterprise AI Adoption
-
Beyond, Inc. to Participate in Upcoming Investor Conferences
-
LCS Announces 2024 Chef of the Year Finalists
-
Form 8.3 - Irish Residential Properties REIT plc
-
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
-
Report on transactions of executives and related parties in ROCKWOOL A/S shares
-
Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial
-
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in Partnership with Boehringer Ingelheim
-
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in Partnership with Boehringer Ingelheim
-
Molecular Templates, Inc. Provides Interim Update
-
Maris-Tech Receives New Order for $225,000 From a Military Drone Manufacturer for a Unique Solution for Unmanned Aircraft Systems
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 31 05 2024] - (CGWL)
-
Coherent Appoints Jim Anderson as Chief Executive Officer
-
Four Charlesbank Portfolio Companies Named to Newsweek’s “America’s Greatest Workplaces for Mental Wellbeing 2024”
-
NKGen Biotech To Present Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy in Solid Tumors at the 6th Annual Allogeneic Cell Therapies Summit 2024
-
InnovAge PACE Recertified as a Great Place to Work
-
Noom Launches Noom Vibe, a Wellness Community and Habit Tracker Built for the Age of GLP-1s
-
Ready Capital to Present at Nareit’s REITweek 2024
-
Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conference
-
AVRICORE HEALTH CORPORATE UPDATE – COMPANY ACHIEVES PROFITABILITY
-
Texas Must Close Primary Elections
-
Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following Treatment with Bizaxofusp When Compared to a Matched External Control Arm at the 2024 ASCO Annual Meeti
-
Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
-
Genesis Offers New Tools and Incentives to Financial Industry Software Developers
-
Denali Therapeutics Announces FDA Has Selected DNL126 (ETV:SGSH) for MPS IIIA (Sanfilippo Syndrome Type A) for START Pilot Program Intended to Accelerate Development of Rare Disease Therapies
-
BriaCell Presents Clinical Efficacy Data at ASCO 2024
-
Tonix Pharmaceuticals Presented New Data on Tonmya™ Suggesting Activity for Improvement in Fibromyalgia-Associated Depression Severity in an Oral Presentation at ASCP Annual Meeting
-
Entera Bio Reports Phase 1 Clinical Data of First-in-Class, Oral PTH(1-34) Peptide Candidate (EB612) for Patients with Hypoparathyroidism at ENDO 2024
-
PetMed Express, Inc. Announces Strategic Updates to Executive Leadership Team
-
STMicroelectronics Announces Status of Common Share Repurchase Program
-
Enphase Energy Launches IQ Battery 5P in Canada
-
KULR Announces Expiration of SEPA Facility and Compliance with NYSE Guidelines on Audit Opinion Disclosure
-
Apogee Minerals Announces Appointment of New Director
-
ASP Isotopes Inc. Receives Purchase Order from a Leading Global Industrial Gases Company for the Supply of Highly Enriched Electronic Gases
-
ORYZON Announces Journal Publication of Final Phase IIa ALICE Results with Iadademstat in The Lancet Hematology
-
Abacus Life and AIMCOR Announce New National Distribution Agreement
-
Replimune Presents Positive Data from RP1 and RP2 Clinical Programs at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Gabelli Funds to Host 16th Annual Media & Entertainment Symposium Thursday, June 6, 2024
-
Core Molding Technologies to Present and Host 1x1 Meetings at the 14th Annual East Coast IDEAS Conference on June 13, 2024
-
Arcutis to Present at the Goldman Sachs 45th Annual Global Healthcare Conference